Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Hackl

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Biotechnology Journal|May 9, 2014
One plus one makes three: adding value by co-transfection of anti-apoptotic genes during transient gene expressionMatthias Hackl, Nicole Borth
Toxicology Reports|December 8, 2017
MicroRNAs and toxicology: A love marriageElisabeth Schraml, Matthias Hackl, Johannes Grillari
Hepatology (Baltimore, Md.)|May 14, 2019
ReplyPatrick Starlinger, Matthias Hackl, Alice Assinger
Mechanisms of Ageing and Development|December 17, 2017
Editorial: Non-coding RNA in aging and age-associated diseases - from intracellular regulators to hormone like actionsMatthias Hackl, Yousin Suh, Johannes Grillari
Trends in Biotechnology|June 8, 2012
miRNAs--pathway engineering of CHO cell factories that avoids translational burdeningMatthias Hackl, Nicole Borth, Johannes Grillari
International Journal of Molecular Sciences|May 20, 2020
microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoringTeresa L Krammer, Manuel Mayr, Matthias Hackl
Biogerontology|May 4, 2010
miR-17-92 cluster: ups and downs in cancer and agingJohannes Grillari, Matthias Hackl, Regina Grillari-Voglauer
Hepatology (Baltimore, Md.)|April 30, 2019
ReplyPatrick Starlinger, David Pereyra, Matthias Hackl, et al.
F1000Research|May 18, 2026
miND (miRNA NGS Discovery pipeline): a small RNA-seq analysis pipeline and report generator for microRNA biomarker discovery studiesAndreas Diendorfer, Kseniya Khamina, Marianne Pultar, et al.
Molecular and Cellular Endocrinology|November 4, 2015
Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases?Matthias Hackl, Ursula Heilmeier, Sylvia Weilner, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Biotechnology Journal|May 9, 2014
One plus one makes three: adding value by co-transfection of anti-apoptotic genes during transient gene expressionMatthias Hackl, Nicole Borth
Toxicology Reports|December 8, 2017
MicroRNAs and toxicology: A love marriageElisabeth Schraml, Matthias Hackl, Johannes Grillari
Hepatology (Baltimore, Md.)|May 14, 2019
ReplyPatrick Starlinger, Matthias Hackl, Alice Assinger
Mechanisms of Ageing and Development|December 17, 2017
Editorial: Non-coding RNA in aging and age-associated diseases - from intracellular regulators to hormone like actionsMatthias Hackl, Yousin Suh, Johannes Grillari
Trends in Biotechnology|June 8, 2012
miRNAs--pathway engineering of CHO cell factories that avoids translational burdeningMatthias Hackl, Nicole Borth, Johannes Grillari
International Journal of Molecular Sciences|May 20, 2020
microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoringTeresa L Krammer, Manuel Mayr, Matthias Hackl
Biogerontology|May 4, 2010
miR-17-92 cluster: ups and downs in cancer and agingJohannes Grillari, Matthias Hackl, Regina Grillari-Voglauer
Hepatology (Baltimore, Md.)|April 30, 2019
ReplyPatrick Starlinger, David Pereyra, Matthias Hackl, et al.
F1000Research|May 18, 2026
miND (miRNA NGS Discovery pipeline): a small RNA-seq analysis pipeline and report generator for microRNA biomarker discovery studiesAndreas Diendorfer, Kseniya Khamina, Marianne Pultar, et al.
Molecular and Cellular Endocrinology|November 4, 2015
Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases?Matthias Hackl, Ursula Heilmeier, Sylvia Weilner, et al.
Pageof 15